Tandlægerne på Torvet i Tønder ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.7% 1.7% 1.3% 1.4% 1.5%  
Credit score (0-100)  75 72 79 77 75  
Credit rating  A A A A A  
Credit limit (kDKK)  5.7 2.6 61.6 29.7 23.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  5,599 5,314 5,599 5,226 6,517  
EBITDA  1,182 1,001 1,182 988 888  
EBIT  791 537 791 479 527  
Pre-tax profit (PTP)  719.0 443.9 719.0 377.4 472.5  
Net earnings  560.8 349.3 560.8 295.8 367.4  
Pre-tax profit without non-rec. items  3,322 444 719 377 472  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  219 145 219 359 277  
Shareholders equity total  2,431 1,981 2,431 2,614 2,867  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,371 3,609 4,371 3,835 5,160  

Net Debt  -676 -236 -676 -742 -1,795  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,599 5,314 5,599 5,226 6,517  
Gross profit growth  135.7% -5.1% 5.4% -6.7% 24.7%  
Employees  9 9 9 9 10  
Employee growth %  800.0% 0.0% 0.0% 0.0% 11.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,371 3,609 4,371 3,835 5,160  
Balance sheet change%  116.4% -17.4% 21.1% -12.3% 34.5%  
Added value  791.4 537.4 791.4 479.2 526.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  2,270 -430 -424 -730 -255  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  14.1% 10.1% 14.1% 9.2% 8.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  106.5% 13.9% 20.0% 11.9% 12.0%  
ROI %  162.1% 24.3% 35.1% 18.5% 18.6%  
ROE %  27.5% 15.8% 25.4% 11.7% 13.4%  

Solidity 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  56.0% 52.3% 56.0% 68.5% 55.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -57.2% -23.5% -57.2% -75.1% -202.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.8 0.5 0.8 1.1 1.1  
Current Ratio  0.9 0.6 0.9 1.2 1.2  
Cash and cash equivalent  676.0 235.5 676.0 741.8 1,794.8  

Capital use efficiency 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -424.9 -698.9 -424.9 -30.4 -147.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  88 60 88 53 53  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  131 111 131 110 89  
EBIT / employee  88 60 88 53 53  
Net earnings / employee  62 39 62 33 37